EXELON AND RAZADYNE

New campaign aims to reduce Rx name confusion | Article from Drug Topics | HighBeam Research Ortho-McNeil Neurologies (OMN) has launched a campaign to warn pharmacists about prescribing and dispensing errors. The campaign centers around two OMN drugs, topiramate (Topamax) and galantamine (Razadyne and Razadyne ER). The situation is a bit of déjà vu for OMN. Galantamine, a drug for Alzheimer's disease, was originally given the brand name Reminyl and marketed by Janssen. However, in more man one instance, it was confused with the diabetes drug glimepiride (Amaryl, Sanofi-Aventis). The two names were similar enough to be easily confused, and compounding the problem was the fact that both products were available in 4-mg strength.